Søgning
Søgning på udtrykket 'mrsa' giver 30 resultater
Dokumenter [6] Sider [2] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [2]
Dokumenter [6]
Udgivet af Sundhedsstyrelsen, 3. udgave
Udgivet af Sundhedsstyrelsen maj 2023. Findes også på www.sst.dk/-/media/Udgivelser/2023/MRSA/Information-om-behandling-af-MRSA-baerertilstand---Dansk.ashx
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
Sider [2]
…er / Pernille Ravn. 09.00-09.15 Erysipelas. Hvilken behandling er bedst? / Gruppe 5. 09.15-09.30 Strategi ved bid fra dyr / Gruppe 6. 09.30-09.45 Sammenfatning erysipelas / Pernille Ravn. 09.45-09.50 Strække ben pause. 09.50-10.00 Intro til MRSA. Præsentation af patientcase / Lotte Ebdrup. 10.00-10.45 (MR)SA ? epidemiologi, patogenese i forhold til hud og knogler / Robert Skov. 10.45-11.00 Kaffe/te ? pause. 11.00-11.20 Spondylodiskitis ? antibiotisk behandling / Gruppe 7. 11.20-12…
… 13.45 – 14.00. Pause. 14.00 – 14.45. Behandling af urinvejsinfektion set fra KMA. Afdelingslæge Frederik Hertz, KMA, RH. 14.45 – 15.00. Kaffe og kage og frugt. 15.00 – 15.35. Bogstavbakterierne - MRSA, CPO, ESBL, VRE – forebyggelse og behandling. Afdelingslæge Frederik Hertz, KMA, RH. 15.35 – 15.45. Evaluering. Overlæge Rikke Krogh-Madsen, Hvidovre / Cheflæge Michael Dalager-Pedersen, Aalborg. .
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Clinical Microbiology and Infection
2.12.2024
To assess the frequency of the novel NaHCO3-responsive phenotype, wherein clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates are rendered susceptible to standard-of-care β-lactams in the presence of NaHCO3, in a collection of 103 clinical US MRSA skin and soft tissue infection (SSTI) isolates and 22 clinical European SSTI isolates. Determined the correlation between specific phenotypic and genotypic metrics and the NaHCO3-responsive phenotype among US SSTI isolates.
Clinical Microbiology and Infection
21.11.2024
Community-onset meticillin-resistant Staphylococcus aureus (MRSA) (CO-MRSA) has been under recognised and under described outside the USA and we welcome this themed issue comprising 4 narrative reviews on the topic which cover a wide range of issues.
Clinical Microbiology and Infection
30.10.2024
Staphylococcus aureus is an important pathogen in many sites, including bloodstream, skin and soft tissue, bone and joints. When infection is caused by methicillin resistant S. aureus (MRSA) therapy is more difficult and outcomes are less favorable. Nasal colonization is associated with increased risk for MRSA infections. The nasal microbiome may play a role in risk for nasal colonization and infection.
BMC Infectious Diseases
4.10.2024
. Abstract. . Background and rationale. Methicillin resistant Staphylococcus aureus (MRSA) colonization increases the risk of MRSA infection. Detecting MRSA colonization can influence postoperative outcomes and prolong hospital stay. The conventional standard culture method for detecting MRSA colonization has limitations in terms of sensitivity and turnaround time. Hence, we sought out use of Xpert PCR kit for prompt evaluat…
BMC Infectious Diseases
18.09.2024
…4 to June 2022 and classified them into C. striatum-BSI group and contamination group; Clinical characteristics, treatments, and outcomes were compared between the C. striatum-BSI group and contamination group, Methicillin-resistant Staphylococcus aureus (MRSA)-BSI and Methicillin-resistant Staphylococcus epidermidis (MRSE)-BSI. . . . Results. Fifty-three patients with positive C. striatum blood cultures were identified. Am…
BMC Infectious Diseases
5.09.2024
. Abstract. . Background. The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains resistant to non-beta-lactam antimicrobials poses a significant challenge in treating severe MRSA bloodstream infections. This study explores resistance development and mechanisms in MRSA isolates, especially after the first dalbavancin-resistant MRSA strain in our hospital in 2016. . . …
Clinical Microbiology and Infection
17.06.2024
This review aims to explore the characteristics of outbreaks of community-acquired community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) in low prevalence areas, to understand the factors involved in its rise, and to translate this knowledge into public health policy and further research needs.
International Journal of Infectious Diseases
22.05.2024
…ssue infections, bacteremia, and endocarditis [1,2]. China Antimicrobial Resistance Surveillance System (CARSS) reported a 46% detection rate of S. aureus in 2020 [3]. The study showed that MRSA prevalence ranged from 0% to 73% at 19 sites in the Asia-Pacific region from 2000 to 2016 [3]. Recently, the rate of MRSA infection has been increasing sharply[4], posing a challenge to the health system in terms of difficult therapy, extended length of hospital stay, expanded health costs, and high mortality [4,5].
PLoS One Infectious Diseases
21.05.2024
by M. Gabriela Cabanilla, Michael L. Bernauer, Liana M. Atallah, Matthew J. Briski, Jason Koury, Cecilia M. Thompson, Chelsea N. Rodriguez, Bernadette Jakeman, Thomas F. Byrd . Background Methicillin-resistant Staphylococcus aureus (MRSA) is associated with high mortality rates. Despite antibiotic therapy, persistent bacteremia is challenging to treat. Combination therapy with ceftaroline has emerged as a potential treatment option; however, the optimal duration and clinical implications after bacteremia c…
Clinical Microbiology and Infection
16.05.2024
Gown and glove use as a component of ‘contact precautions’ was first recommended by the United States Healthcare Infection Control Practices Advisory Committee (HICPAC) in 1996 and remains widely adhered to today (1, 2). Despite a lack of randomised trial evidence in support of this practice, donning of gowns and gloves upon entry to the patient area (room or cubicle) continues to be ‘strongly recommended’ when the patient is infected or colonised with pathogens of epidemiological importance and the…
Clinical Microbiology and Infection
15.03.2024
This study aims to evaluate two commercial broth microdilution (BMD) systems, E1-185-100 (Merlin) and FDANDPF (ThermoFisher) for dalbavancin susceptibility testing in comparison with reference broth microdilution assay.
BMC Infectious Diseases
25.02.2024
. Abstract. . Background. While there is a high burden of methicillin-resistant Staphylococcus aureus (MRSA) infections among pediatric patients, studies on the molecular epidemiology of MRSA infections in Korean children since the 2010s are lacking. This study aimed to investigate the molecular genotypes and clinical characteristics of MRSA isolates from children with MRSA bacteremia at Asan Medical Center Children’s Hosp…
Clinical Microbiology and Infection
24.02.2024
Globally, the isolation of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) harbouring both the Panton–Valentine leucocidin (PVL) and toxic shock syndrome toxin 1 (TSST-1) genes is rare. However, we encountered an outbreak of the ST22-PT clone exhibiting this phenotype in Japan. Notably, the TSST-1 gene was duplicated in most of the strains. This study aimed to elucidate the mechanisms underlying this gene duplication.
Antimicrobial Agents And Chemotherapy
21.02.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
BMC Infectious Diseases
17.02.2024
… . Aims. We investigated the antibacterial efficacy of Umonium38 and Virkon® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment. . . . Methods and results. Umonium38 was diluted to 0.5%, 1.0%, 1.5%, 2.0%, 2.5% and 3%, tested against the bacterial strains at v…
Antimicrobial Agents And Chemotherapy
13.02.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Clinical Microbiology and Infection
11.01.2024
Staphylococcus aureus is a versatile organism, capable of existing as a commensal organism while also possessing pathogenic potential. The emergence of clinically and genetically distinct strains of methicillin-resistant S. aureus (MRSA), termed community-onset MRSA (CO-MRSA), resulted in an epidemic of invasive and skin and soft tissue infections (SSTI) in otherwise healthy individuals without traditional risk factors. Colonization with S. aureus is a risk factor for developing infection and also a source …
Clinical Microbiology and Infection
10.01.2024
Methicillin-resistant Staphylococcus aureus (MRSA) colonization increases infection risk in both patients and healthy individuals. Decolonization therapy has been proven to reduce S. aureus infections, but data on the effectiveness of individual decolonization strategies in community-onset MRSA carriage are scarce.
Clinical Microbiology and Infection
23.11.2024
To evaluate the effectiveness of ceftaroline vs. vancomycin or daptomycin in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections (MRSA-BSIs).
Aktuelle smitsomme sygdomme [2]
Aktuelle smitsomme sygdomme [2]
Medscape Infectious Diseases
13.02.2024
Researchers who uncovered a fresh class of antibiotics used a new process — explainable AI — that could propel drug discovery. . Medscape Medical News
Eurosurveillance latest updates
27.09.2024
… in MDRO-negatives (472/2,020). Among 397 owner–pet pairs, we identified one pair sharing genotypically indistinguishable pathogens (0.3%). A risk factor analysis of pet ownership was performed for carriers of meticillin-resistant Staphylococcus aureus (MRSA) (OR = 0.662; 95% CI: 0.343–1.277), vancomycin-resistant enterococci (VRE) (OR = 0.764; 95% CI: 0.522–1.118) and multidrug-resistant Gram-negative bacteria (MDR-GNB) (OR = 0.819; 95% CI: 0.620–1.082). Colonisation with MDRO was rare …